Weekend Daily: The Biotech Sector Should Come Back First

by

The market has turned for the worst in recent weeks and continues to fall in a bear market fashion.

Most of our portfolio strategies are holding more than 50% cash, some are utilizing inverse ETFs, and in my discretionary trading service, we are largely in cash. 

We are looking for profitable opportunities to deploy dry powder.

One of the areas we are watching is the biotech sector, represented above by the iShares Biotech ETF (IBB) or AKA “Big Brother.”

The biotech industry is often considered risky since biotech companies, especially in the small/micro-cap sector, are often speculative, and individual stocks can suffer vicious losses.

Yet, many areas of biotech show incredible promise, including regenerative medicine, gene therapy, genomics, new advances in treating cancer and autoimmune disorders, to name just a few. 

IBB should be on your shopping list for a few reasons.

1. (IBB) “Big Brother” is one of our Modern Family members and is trading well above the June lows while the indices tested them on Friday-we call that relative strength.

2. Biotech received a $2 Billion Boost from the US government earlier this week.

  • One of the goals is cutting cancer deaths in half in the next 25 years.
  • The outcome of this government biotech initiative is unknown but can only be seen as a positive for the industry.

3. IBB is sitting at an interesting pivotal support level.

  • IBB closed Friday over 115.
  • Next key level to clear and give us a good risk point for entry is 118.

We are monitoring the biotech sector for a near-term rebound because of rising worldwide demand for medical advancements, aging populations, and new government backing for research. 

For more information on how to invest profitably in sectors like biotech, please reach out to Rob Quinn, our Chief Strategy Consultant, by clicking here.

Mish’s Upcoming Seminars

ChartCon 2022: October 7-8th, Seattle (FULLY VIRTUAL EVENT). Join me and 16 other elite market experts for live trading rooms, fireside chats, and panel discussions. Learn more here.

The Money Show: Join me and many wonderful speakers at the Money Show in Orlando, beginning October 30th running thru November 1st; spend Halloween with us!

Get your copy of Plant Your Money Tree: A Guide to Growing Your Wealth and a special bonus here.


Follow Mish on Twitter @marketminute for stock picks and more. Follow Mish on Instagram (mishschneider) for daily morning videos. To see updated media clips, click here.

Mish in the Media

A business cycle is about 6-7 years – where are the indices now and what should you watch for? Mish discusses this question in this appearance on Fox’s Making Money with Charles Payne.

Mish discusses how the Fed needed to be more aggressive, as they now have more to raise this year, with a panel on Coindesk.

See Mish’s latest article for CMC Markets, titled “Our Go-To Trade Indicator Post-Fed Meeting“.

Mish discusses price, momentum and market psychology in this appearance on Business First AM.


ETF Summary

  • S&P 500 (SPY): At least held June lows, for what’s it worth. 362 support, 371 resistance.
  • Russell 2000 (IWM): Held June lows; 163 support, 170 resistance 170.
  • Dow (DIA): Broke June lows-harbinger? 292 support, 300 resistance.
  • Nasdaq (QQQ): Held June lows; 269 support, 280 resistance.
  • KRE (Regional Banks): Relative outperformer holding the 6-month calendar range high; 60 pivotal.
  • SMH (Semiconductors): Held the 6-month calendar range low, making 191 pivotal.
  • IYT (Transportation): Transports unhappy, unless Friday’s gap turns out an island bottom.
  • IBB (Biotechnology): 112 support, 118 resistance.
  • XRT (Retail): Held the 6-month calendar range low; 55 support, 60 resistance.

Mish Schneider

MarketGauge.com

Director of Trading Research and Education

Related Posts